Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments

Gliomas are one of the most lethal types of cancers accounting for ∼80% of all central nervous system (CNS) primary malignancies. Among gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15  months. Recent molecular characterization studies...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Pharmacol
Hlavní autoři: Alghamri, Mahmoud S., McClellan, Brandon L., Hartlage, Carson S., Haase, Santiago, Faisal, Syed Mohd, Thalla, Rohit, Dabaja, Ali, Banerjee, Kaushik, Carney, Stephen V., Mujeeb, Anzar A., Olin, Michael R., Moon, James J., Schwendeman, Anna, Lowenstein, Pedro R., Castro, Maria G.
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8167057/
https://ncbi.nlm.nih.gov/pubmed/34084145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.680021
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky